Risk of suicidal events with atomoxetine compared to stimulant treatment: a cohort study - Linden S, Bussing R, Kubilis P, Gerhard T, Segal R, Shuster JJ, Winterstein AG.

BACKGROUND: Antidepressant effects on increased suicidality in children have raised public concern in recent years. Approved in 2002 for attention-deficit/hyperactivity disorder treatment, the selective noradrenalin-reuptake-inhibitor atomoxetine was initi...
Source: SafetyLit - Category: Global & Universal Tags: Age: Adolescents Source Type: news